• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[使用苯基和色满取代化合物筛选降胆固醇药物的研究(作者译)]

[Studies on screening for cholesterol-lowering agents using phenyl- and chromane substituted compounds (author's transl)].

作者信息

Yoshida K, Nakamura H

出版信息

Hokkaido Igaku Zasshi. 1976 Nov;51(6):513-8.

PMID:1035574
Abstract

Sixteen phenyl compounds and twenty chromane compounds substituted by geranoyl, farnesoyl, phytonoyl, retinoyl and linolenoyl synthesized by Eisai Co., Ltd were used. Male mice were fed a cholesterol or a normal basal diet which 0.3% compound was added for 10 or 31 days. Effect of these compounds on the cholesterol level of serum and liver were examined and compared to that of CPIB. As a results of this series of experiments hypocholesteremic agents were screened as follows: 3 phenyl compounds (N76009, N76011, N76012), and 6 chromane compounds (N-76-H-23, N-76-H-25, N-76-H-27, N-76-H-35, N-76-H-37, N-76-H-38). Among these compounds, N-76-H-38, (formula: see text) was found to be the most favorable cholesterol-lowering agent.

摘要

使用了由卫材株式会社合成的16种苯基化合物和20种被香叶酰基、法尼基酰基、植基、视黄酰基和亚麻酸酰基取代的色满化合物。雄性小鼠被喂食添加了0.3%化合物的胆固醇或正常基础饮食,持续10天或31天。检测了这些化合物对血清和肝脏胆固醇水平的影响,并与CPIB的影响进行比较。作为这一系列实验的结果,筛选出了如下降胆固醇药物:3种苯基化合物(N76009、N76011、N76012)和6种色满化合物(N-76-H-23、N-76-H-25、N-76-H-27、N-76-H-35、N-76-H-37、N-76-H-38)。在这些化合物中,N-76-H-38(化学式:见正文)被发现是最有利的降胆固醇药物。

相似文献

1
[Studies on screening for cholesterol-lowering agents using phenyl- and chromane substituted compounds (author's transl)].[使用苯基和色满取代化合物筛选降胆固醇药物的研究(作者译)]
Hokkaido Igaku Zasshi. 1976 Nov;51(6):513-8.
2
[Studies on the mechanism of lowering of the cholesterol level by ethyl-alpha-p-chlorophenoxy-isobutyrate (clofibrate) (author's transl)].[α-对氯苯氧异丁酸乙酯(安妥明)降低胆固醇水平的机制研究(作者译)]
Hokkaido Igaku Zasshi. 1976 Jul;51(4):289-97.
3
Inhibitors of acyl-CoA:cholesterol O-acyltransferase. synthesis and pharmacological activity of (+/-)-2-dodecyl-alpha-phenyl-N-(2,4,6-trimethoxyphenyl)-2H-tetrazole-5- acetamide and structurally related tetrazole amide derivatives.酰基辅酶A:胆固醇O-酰基转移酶抑制剂。(±)-2-十二烷基-α-苯基-N-(2,4,6-三甲氧基苯基)-2H-四唑-5-乙酰胺及结构相关的四唑酰胺衍生物的合成与药理活性
J Med Chem. 1996 Jun 7;39(12):2354-66. doi: 10.1021/jm960170f.
4
Synthesis and hypolipidemic evaluation of beta-alkylaminopropiophenone and beta-alkylaminopropio-2'-naphthone derivatives in rodents.
Pharmazie. 1996 Apr;51(4):199-206.
5
Hypolipemic activity of clofibrate-related compounds.氯贝丁酯相关化合物的降血脂活性。
Arzneimittelforschung. 1975 Nov;25(11):1686-92.
6
Hypolipemic activity of clofibrate-related compounds. 2nd Communication.氯贝丁酯相关化合物的降血脂活性。第二篇通讯。
Arzneimittelforschung. 1977 Jul;27(7):1421-4.
7
Cholesterol lowering action of vitamin P-like compounds in rats.类维生素P化合物对大鼠的降胆固醇作用。
Indian J Exp Biol. 1981 Aug;19(8):787-9.
8
Anticholesterolemic effect of 3,4-di(OH)-phenylpropionic amides in high-cholesterol fed rats.3,4-二(羟基)苯基丙酰胺对高胆固醇喂养大鼠的抗胆固醇作用
Toxicol Appl Pharmacol. 2005 Oct 1;208(1):29-36. doi: 10.1016/j.taap.2005.01.012.
9
Hypolipidemic activity of some derivatives of 6H-dibenzo[b,d]pyran.6H-二苯并[b,d]吡喃某些衍生物的降血脂活性
Arzneimittelforschung. 1984;34(8):864-9.
10
[Enzyme-inducing activities of hypolipidemic agents and ultrastructural changes of the liver elicited by clofibrate (author's transl)].[降血脂药物的酶诱导活性及氯贝丁酯引起的肝脏超微结构变化(作者译)]
Fukuoka Igaku Zasshi. 1974 Jul 25;65(7):465-72.